A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 6, 2011, Pages 431-434

  Pramanik, Vishmadeb ^a   Sarkar, Biswanath N ^a   Kar, Madhuchanda ^b   Das, Gautam ^c   Malay, Barman K ^c   Sufia, Khannam K ^d   Lakkakula, Bhaskar V K S ^e   Vadlamudi, Rao R ^a,f  

^a Anthropological Survey of India   (India)

^b Cancer Center Welfare Home and Research Institute   (India)

^c CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

^d NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^e SRI RAMACHANDRA UNIVERSITY   (India)

^f UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; K RAS PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GALLBLADDER CARCINOMA; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PHENOTYPE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CODON; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INDIA; MALE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 79959223615     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0194     Document Type: Article

References (28)

1. Bodzioch S, Ogiela MR (2009) New approach to gallbladder ultrasonic images analysis and lesions recognition. Comput Med Imaging Graph 33:154-170.
2. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689. (Pubitemid 19213607)
3. Brink M, de Goeij AF, Weijenberg MP, et al. (2003) K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 24:703-710. (Pubitemid 36592405)
4. Cubells JF, Kobayashi K, Nagatsu T, et al. (1997) Population genetics of a functional variant of the dopamine betahydroxylase gene (DBH). Am J Med Genet 74:374-379.
5. Daly BD, Cheung H, Arnold M, Metreweli C (1993) Ultrasound in the diagnosis of gall-bladder carcinoma in Chinese patients. Clin Radiol 48:41-44. (Pubitemid 23219043)
6. Fernandez E, La Vecchia C, D'Avanzo B, et al. (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3:209-212. (Pubitemid 24172532)
7. Geetha A (2002) Evidence for oxidative stress in the gall bladder mucosa of gall stone patients. J Biochem Mol Biol Biophys 6:427-432. (Pubitemid 35469243)
8. Grimmond SM, Raghavan D, Russell PJ (1992) Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urol Res 20:121-126.
9. Gupta SK, Shukla VK (2004) Silent gallstones: a therapeutic dilemma. Trop Gastroenterol 25:65-68.
10. Hofacker IL (2009) RNA secondary structure analysis using the Vienna RNA package. Curr Protoc Bioinformatics Chapter 12: Unit 12 2.
11. Hsing AW, Bai Y, Andreotti G, et al. (2007) Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 121:832-838. (Pubitemid 47106214)
12. Iwase T, Nakazawa S, Yamao K, et al. (1997) Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. Hepatogastroenterology 44:1457-1462. (Pubitemid 27450195)
13. Kamisawa T, Tsuruta K, Okamoto A, et al. (2009). Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas 38:890-895.
14. Kapoor VK, McMichael AJ (2003) Gallbladder cancer: an "Indian" disease. Natl Med J India 16:209-213.
15. Kato K, Akai S, Tominaga S, Kato I (1989) A case-control study of biliary tract cancer in Niigata Prefecture, Japan. Jpn J Cancer Res 80:932-938. (Pubitemid 20028806)
16. Kranenburg O (2005) The KRAS oncogene: past, present, and future. Biochim Biophys Acta 1756:81-82. (Pubitemid 41773135)
17. Maurer KJ, Carey MC, Fox JG (2009) Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 136:425-440.
18. Nandakumar A, Gupta PC, Gangadharan P, et al. (2005). Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer 116:740-754. (Pubitemid 41102252)
19. O'Connell P, Lathrop GM, Law M, et al. (1987) A primary genetic linkage map for human chromosome 12. Genomics 1:93-102.
20. Rai A, Mohapatra SC, Shukla HS (2004) A review of association of dietary factors in gallbladder cancer. Indian J Cancer 41:147-151. (Pubitemid 40203357)
21. Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591-1602. (Pubitemid 43376420)
22. Reich D, Thangaraj K, Patterson N, et al. (2009) Reconstructing Indian population history. Nature 461:489-494.
23. Sambrook J, Fritsch E, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Wang DQ, Cohen DE, Carey MC (2009) Biliary lipids and cholesterol gallstone disease. J Lipid Res 50 Suppl: S406-S411.
25. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J (1999) Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 30:21-25. (Pubitemid 29037389)
26. Yamaguchi K, Enjoji M (1988) Carcinoma of the gallbladder. A clinicopathology of 103 patients and a newly proposed staging. Cancer 62:1425-1432.
27. Zatonski WA, La Vecchia C, Przewozniak K, et al. (1992) Risk factors for gallbladder cancer: a Polish case-control study. Int J Cancer 51:707-711.
28. Zenker M, Lehmann K, Schulz AL, et al. (2007). Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet 44:131-135.